baber/WOPTO huggingface dataset:
Patent IL-132572-A0 (IL)
Title: Process and device for recovering raw materials from waste and residues
IPC: C22B34/32
Filed: 1998-04-28
Abstract: A process is disclosed for recovering raw materials, in particular heavy metals such as chromium, zinc, copper, lead, or nickel, by separation from waste and residues, wherein a liquid or viscous starting mixture and/or a starting mixture composed of crushed or ground components is first prepared. The invention is characterized in that the raw materials are separated by a thermochemical treatment. The liquid, viscous and/or solid starting mixture is first mixed with additives, depending on its composition, then subjected to a thermal treatment in an oven. The atmosphere in the oven flows through the starting mixture and the suspended materials thus generated as flakes or dust are conveyed out of the oven through a filter installation with several stages in which they are separated from the waste gas. The first filter is designed as a hot filter, after which the waste gas is cooled and after flowing through at least a second filter, pre-heated and then burnt at a high temperature. The process of the invention may be used, for example, to recover chromium (III) oxide from chromium-containing residues or zinc oxide from zinc-containing residues. Formation of chromium (III) oxide from chlorine-containing wastes occurs by formation and decomposition of chromyl chloride. Additives suitable for use in the invention may include those that comprise aluminum, aluminum oxide, iron, iron oxide, chlorine-containing material, sulfur-containing, milled plastics, granulated plastics, peroxides, silicon oxide, magnesium oxide or combinations thereof.
Patent IL-135002-A0 (IL)
Title: Method for preparing optionally substituted benzofuranones
IPC: C07D307/83
Filed: 1998-09-30
Abstract: The invention relates to an improved method for preparing optionally substituted benzofuran-3-ones which can be used as initial products for preparing 3-(1-hydroxyphenyl-1-alkoximinomethyl) dioxazines. These later are known starting materials for preparing compounds with fungicidal properties.
Patent IL-137672-A0 (IL)
Title: Derivatives of branched-chain lipophilic molecules and uses thereof
IPC: C07F9/10
Filed: 2000-08-03
Abstract: Novel phospho-derivatives of branched-chain lipophilic molecules useful for permeabilizing biological barriers and for inhibiting tumor growth are disclosed. Pharmaceutical compositions comprising phospho-derivatives of branched-chain lipophilic molecules and their uses are also disclosed.
Patent IL-141706-A0 (IL)
Title: Call maintenance during position location
IPC: H04W64/00
Filed: 1999-09-02
Abstract: The present invention is a novel and improved method and apparatus for performing position location in wireless communications system. In one embodiment the invention comprises a method in a subscriber unit (10) for performing position location in a CDMA wireless communications system having a base station (12), the method comprising: receiving a position location request containing aiding information from the base station (12) over a first receive frequency; in response to the position location request, tuning a receiver (52, 54, 102, 104) of the subscriber unit (10) away from the first receive frequency to a position location frequency in order to receive position location information; and receiving information over the position location frequency and using the received information to perform a position location procedure, the method being characterized by: including data transition boundary information in the aiding information.
Patent IL-141785-A0 (IL)
Title: A pharmaceutical composition containing an ap2 inhibitor
IPC: A61K45/00
Filed: 1999-09-13
Abstract: A method is provided for treating atherosclerosis and related diseases, employing an aP2 inhibitor or a combination of an aP2 inhibitor and another antiatherosclerotic agent, for example, an HMG CoA reductase inhibitor such as pravastatin.
Patent IL-147755-A0 (IL)
Title: Multi-dose erythropoietin formulations
IPC: A61K47/10
Filed: 2000-07-21
Abstract: The present invention is directed to multi-dose erythropoietin formulations for parenteral administrations. The formulations contain one or more of the following preservatives benzethonium chloride, phenoxyethanol and phenylethyl alcohol.
Patent IL-149062-A0 (IL)
Title: Improved method for detecting acid resistant microorganisms in the stool
IPC: C12N15/09
Filed: 2000-10-12
Abstract: Detecting infection by an acid-resistant microorganism (A), in a mammal, comprises using immunochromatography.  Detecting infection by an acid-resistant microorganism (A), in a mammal, comprises  (a) preparing an immunochromatographic test strip having a sample application zone (I); (b) applying a fecal sample, containing an antigen (Ag) of (A) to (I); (c) incubating the sample with: (i) a first receptor (R1) to form a complex with Ag; or (ii) at least two different R1 to form a three-part complex with Ag, where R1 are specific for an Ag which, after passage through the intestines, at least in some mammals, retains a native (or corresponding) structure against which the mammal produces antibodies (when immunized or infected with (A), or its extracts, lysates or derived proteins (or fragments) or synthetic peptides); (d) immobilizing a second receptor (R2), able to bind to the complex formed between Ag and R1 to an analytical region; (e) transporting the first complex; (f) forming a second complex with R2 in the analytical region; and (g) detecting the complex. Independent claims are also included for the following:  (1) an immunochromatography test device, especially for the new process, that comprises (I), an incubation system, an analytical region and a system for transporting the Ag-R1 complex; (2) monoclonal antibodies (MAb), their fragments or derivatives, that have a variable region comprising at least one of 24 specified CDRs (complementarity-determining regions), given in the specification;  (3) an aptamer (i) that binds specifically to the same epitope as MAb; (4) an epitope (ii) that binds specifically to MAb or (i); (5) an antibody, or its fragments or derivatives, that bind specifically to (ii); and (6) a kit containing at least one test device of (1).
Patent IL-151660-A0 (IL)
Title: Method for isolating and culturing unculturable microorganisms
IPC: C12N1/00
Filed: 2002-09-09
Abstract: The invention provides a method for isolating and culturing a previously unculturable microorganism, which comprises: (i) collecting a sample from an environmental source; (ii) counting/estimating the number of microorganisms in the sample; (iii) diluting the sample in an appropriate medium; (iv) adding a gelating agent such as to entrap one or more microorganisms within a sphere of the gelating agent; (v) coating the spheres containing the entrapped microorganism(s) with a natural or synthetic polymer to form a polymeric membrane; (vi) incubating the coated spheres in the original environment for an appropriate time; (vii) cutting the spheres and scanning for microorganisms colonies; and (viii) isolating the microorganisms, and repeating steps (iii) to (vii) until a pure clone of said previously unculturable microorganism is obtained.
Patent IL-154529-A0 (IL)
Title: Antisense insulin-like growth factor binding protein (igfep)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy
IPC: A61P5/24
Filed: 2001-09-13
Abstract: Compositions and a method are provided for the treatment of prostate and other endocrine tumors in mammals, including humans, by administration of an antisense oligodeoxynucleotide (ODN) which is complementary to a portion of the gene encoding IGFBP-2. Using the Shionogi tumor model in vitro and in vivo, the administration of such an ODN was shown to reduce proliferation of tumor cells, and also to delay the progression to androgen independence. Thus, treatment of prostate and other hormone-regulated cancer in mammals, including humans, and delay of the progression of prostate tumors to androgen independence is accomplished by administering to the mammal a therapeutically effective amount of an antisense oligodeoxynucleotide which is complementary to a portion of the nucleic acid sequence encoding IGFBP-2 and which reduces the amount of IGFBP-2 in the treated cells.
Patent IL-154535-A0 (IL)
Title: Flexible container having flat walls
IPC: B31B37/74
Filed: 2001-08-28
Abstract: A flexible container and method for making same are provided. The container comprises a base portion including a bottom, side walls, and an interior, the bottom defining a substantially flat planar surface when the container houses product and the container rests on its bottom, an upper panel portion, that is designed to be received within the interior of the base portion and includes side panels that define a closure member, the upper panel being so constructed and arranged to define a substantially flat surface when the closure member is closed and portions of the upper panel are folded over, the upper panel includes a portion that is sealed to the base portion, and a pair of handles may also be coupled to the base portion.
Patent IL-159364-A0 (IL)
Title: A b7 ligand for use in a method for regulating functional ctla4 positive t cell interactions with b7 positive cells
IPC: G01N33/53
Filed: 2003-12-15
Abstract: The invention identifies the CTLA4 receptor as a ligand for the B7 antigen. The complete amino acid sequence encoding human CTLA4 receptor gene is provided. Methods are provided for expressing CTLA4 as an immunoglobulin fusion protein, for preparing hybrid CTLA4 fusion proteins, and for using the soluble fusion proteins, fragments and derivatives thereof, including monoclonal antibodies reactive with B7 and CTLA4, to regulate T cell interactions and immune responses mediated by such interactions.
Patent IL-161603-A0 (IL)
Title: Thymosin augmentation of genetic immunization
IPC: A61P43/00
Filed: 2002-10-28
Abstract: This invention describes the use of thymosin to augment cellular immune responses to hepatitis C virus. Methods for immunizing a subject susceptable to hepatitis C virus infection against such infection, comprising administering to the subject one or more polynucleotides encoding one or more hepatitis C virus peptides, in combination with one or more thymosins, are disclosed. Compositions suitable for immunizing against hepatitis C virus, comprising one or more polynucleotides encoding one or more hepatitis C virus peptides, and one or more thymosins, are also disclosed.
Patent IL-181740-A0 (IL)
Title: THERAPEUTIC AGENTS TARGETING THE NCca-atp CHANNEL AND METHODS OF USE THEREOF
Filed: 2007-03-06
Abstract: The present invention is directed to therapeutic compositions targeting the NC Ca-ATP  channel of an astrocyte, neuron or capillary endothelial cell and methods of using same. More specifically, antagonists of the NC Ca-ATP  channel are contemplated. The compositions are used to prevent cell death and to treat secondary damage associated with spinal cord injury.
Patent IL-184429-A0 (IL)
Title: Glp-1 fusion proteins
IPC: C12N15/02
Filed: 2007-07-05
Abstract: The present invention relates to glucagon-like-1 compounds fused to proteins that have the effect of extending the  in vivo  half-life of the peptides. These fusion proteins can be used to treat non-insulin dependent diabetes mellitus as well as a variety of other conditions.
Patent IL-188439-A0 (IL)
Title: Alertness sensing spectacles
Filed: 2007-12-26
Abstract: Spectacles for use in an eye monitoring system include a pair of ocular frames and a sensor unit adapted to be positioned adjacent an eye of the wearer. A nose bridge connects the ocular frames and incorporates an adjustment mechanism for adjusting the vertical position of the sensor unit relative to the eye. A frame arm extends from the outer edge of each ocular frame and is adapted to fit over the ear of a wearer. The sensor unit incorporates two infra red emitters at different angles and an infra red detector recessed into the surface of the unit to reduce the proportion of signal received by said detector which is not from the signal emitter reflected by the eye or eyelids.
Patent IL-190643-A0 (IL)
Title: Novel dihydropseudoerythromycin derivatives
Filed: 2008-04-06
Abstract: A compound represented by the formula [I] wherein each symbol is as defined in the specification or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing the compound as an active ingredient.
Patent RO-126230-A0 (RO)
Title: Articulated steering mechanism with gear wheels
Inventor: VIŞA ION
IPC: F24S50/20
Filed: 2010-11-08
Abstract: The invention relates to a mechanism for steering photovoltaic modules or thermal collectors in view of maximization of the amount of solar energy collected thereby. According to the invention, the mechanism comprises a plane articulated triangular mechanism consisting of a base (1), a balance lever (2), a linear actuator (D) as well as a gear having two toothed wheels (3 and 4) articulated to the balance lever (2), the first wheel (3) being integral with a piston of the actuator (D) and the second wheel (4) being integral with a support pillar of a solar platform, where, under the action of the actuator (D), the first wheel (3) imparts to the second wheel (4) a high angular travel of more than 250° while exhibiting a minimal gauge, an easy construction and the transmission of forces without blocking tendency.
Patent AP-2004003150-A0 (AP)
Title: Low foaming formulation of glyphosate
Inventor: BARNES CLYDE JAMES III
IPC: A01N57/20
Filed: 2003-03-21
Abstract: A low-foaming herbicidal composition comprises glyphosale and a poly(alkylene oxide) alkanol having the formula R1R2CH-Rr(OR4)n-OH (I) wherein R1 and R2 are methyl or ethyl, R3 is a straight chain alkylene group comaining from 5 to 12 Q carbon atoms, R4 is an alkylene group containing 2 or 3 carbon atoms and n is from 4 to 20. Especially preferred is ethoxylated. propoxylated or mixed alkoxylated/propoxylated iso-lridecyl alcohol wherein the degree of alkoxylation is from 6 to 14, for example iso-tridecyl alcohol having 8 polyethylene oxide units. Preferred compositions additionally contain an alkylglycoside.
Patent MA-24343-A1 (MA)
Inventor: PETER WORTHINGTON HAMILTON
IPC: C09J7/22
Filed: 1997-01-08
Abstract: A substance delivery system has a three dimensional structure with outermost surface features and spaces for containing a substance. The substance has a level below the outermost surface features such that the substance is protected from inadvertent contact with external surfaces. The substance remains protected until the three dimensional structure is sufficiently deformed into a substantially two dimensional structure and the substance is thereby exposed to contact an external surface without compliance of the external surface being necessary. Deforming is preferably achieved by a compression force, wherein the outermost surface features of the three dimensional structure deform in a direction of the compression force. A method of making the three dimensional material includes the steps of coating a substance onto a forming surface, transferring the coating of substance from the forming surface to a piece of material, and forming the piece of material into a three dimensional structure on the forming surface while the substance is in contact with the forming surface.
Patent MA-27799-A1 (MA)
Title: DERIVES DE L'AZAINDOLE COMME INHIBITEURS DU FACTEUR Xa
Inventor: URMANN MATTHIAS
IPC: A61P7/02
Filed: 2005-11-08
Abstract: La présente invention concerne des composés représentés par la formule (I) dans laquelle R0, R1, R2, R3, Q, V, G et M ont la signification donnée dans les revendications. Lesdits composés sont des composés pharmacologiquement actifs, ils présentent un fort effet antithrombotique et peuvent par exemple servir à la thérapie et à la prophylaxie de troubles cardiovasculaires tels que des maladies thromboemboliques et des resténoses. Lesdits composés sont par ailleurs des inhibiteurs réversibles du facteur Xa (FXa) et/ou du facteur VIIa (FVIIa) des enzymes de coagulation sanguine, et peuvent être employés dans le cas de troubles caractérisés par une activité indésirable du facteur Xa et/ou du facteur VIIa ou dans le traitement ou la prévention de troubles nécessitant une inhibition du facteur Xa et/ou du facteur VIIa. L'invention concerne par ailleurs des procédés de fabrication des composés représentés par la formule (I), leur utilisation, notamment en tant que principes actifs dans des agents pharmaceutiques, et des préparations pharmaceutiques contenant lesdits composés.
Patent MA-28354-A1 (MA)
Inventor: SCHWARTZ JEAN-CHARLES
IPC: A61K31/439
Filed: 2006-08-10
Abstract: The present invention concerns new combinations of an anti-emetic agent and an enkephalinase inhibitor, the uses of said combinations for treating diarrhea and/or gastroenteritis.
Patent MA-60467-A1 (MA)
Title: Composition de rapamycine
Inventor: ATKINSON HARTLEY
IPC: A61K31/436
Filed: 2021-11-04
Abstract: La rapamycine est une substance thérapeutique médicalement connue. Un problème avec la rapamycine est qu'elle est assez instable et sujette à une dégradation chimique pendant le stockage. Ceci peut conduire à un médicament devenant "insuffisamment fort" pendant sa durée de conservation. Un objet de l'invention est de remédier au moins en partie à ce problème. L'invention concerne une composition pour traitement topique, comprenant de la rapamycine en tant que principe actif ; un véhicule comprenant de la monolaurine, par exemple sous forme de monolaurate de glycéryle et de la monomyristine, par exemple en tant que monomyristate de glycéryle ; et de l'eau en tant que solvant.
Patent UY-26886-A1 (UY)
Title: Polimorfos de un análogo de epotilona
Inventor: GUO ZHENRONG
IPC: A61P35/00
Filed: 2001-08-15
Abstract: Se proporcionan, de acuerdo con la presente invención, dos polímeros cristalinos, denominados forma A y forma B respectivamente, así como mezclas de los mismos, de un análogo de epotilona representado por la fórmula. También se proporcionan métodos para formar los polimorfos novedosos, métodos terapéuticos que los utilizan y formas de dosificación farmacéutica que los contienen.
Patent UY-28957-A1 (UY)
Inventor: RODRIGUEZ ALVARO MOMBRU
IPC: C01B31/02
Filed: 2005-06-10
Abstract: A process of preparing magnetic graphitic materials from graphite in a second container (3) that reacts with one of more transition metal oxide and in a first container (2) at a volume ratio of 1:1, in a closed reactor (1), heated up to a temperature between 600° C. and the melting temperature of the transition oxide (s) for 6 to 36 hours, under a pressure of 10 atmospheres with the help of a transfer inert gas through an inlet (5) and vacuum between 10−2 torr to 10−7 torr through an outlet (6), obtaining at the end of the process a graphitic material with long-lasting magnetic properties at room temperature. The material obtained exhibits a complex structure, with pores, bunches, pilings and edges of exposed graphenes and finds application in nanotechnology, magnetic images in medical science, applications in communication, electronics, sensors, even biosensors, catalysis or separation of magnetic materials.
Patent UY-29018-A1 (UY)
Title: Pirimidina 2 - sustituidas, procedimientos para su obtencinn y el uso de las mismas para combatir hongos nocivos
Inventor: GROTE DR THOMAS
IPC: A01N33/00
Filed: 2005-07-14
Abstract: La invencinn se refiere a pirimidinas 2 - sustituidas de la fnrmula I, en la que el endice n y los sustituyentes R1 a R4 , (B) , ase como L tiene las definiciones indicadas en la descripcinn, e Y representa un grupo -O- o -S- , ase como A procedimientos para su obtencinn, productos pesticidas que las contienen y procedimientos para combatir hongos nocivos y pestes animales, valicndose de los compuestos segun la invencinn.
Patent UY-29315-A1 (UY)
Title: Metodo de fabricacion de leche en polvo modificada adecuada para uso como extensor o reemplazante de la caseina de cuajo
Inventor: HARVEY JANET
IPC: A23C9/00
Filed: 2005-12-23
Abstract: Un método para preparar un concentrado de proteínas lácteas, producto aislado de proteínas lácteas o caseína micelar, que le imparte la suficiente funcionalidad a dicho producto como para que pueda ser utilizado como reemplazante o extensor de la caseína de cuajo, en particular en productos análogos del queso.
Patent UY-30656-A1 (UY)
Title: Dispositivo con un mecanismo de rodamiento para sujetar planchas y elementos separadores
Inventor: HAGGER STEFAN
IPC: E06B3/42
Filed: 2007-10-19
Abstract: Mecanismo de rodamiento para sujetar una plancha, comprendiendo al menos un rodamiento sujeto por un elemento magnético y/o apoyado sobre una superficie de rodamiento de un riel que comprende una parte central y una o dos laterales, dado el caso, con una base, en cuya parte superior proporciona la superficie del rodamiento, caracterizado porque el mecanismo de rodamiento, y un dispositivo de fijacion están unidos por un lado al mecanismo de rodamiento y por el otro a la plancha con dos piezas de montaje, montadas cada una en una cara en la parte superior de la plancha o dentro de una ranura de la plancha.
Patent ZW-24286-A1 (ZW)
Title: A method for the preparation of a water-in-oil type emulsion explosive and an oxidizer composition for use in the method
Inventor: HANS EHRNSROM
IPC: C06B47/14
Filed: 1986-12-09
Abstract: A method and an oxidizing composition for preparation of a water-in-oil type emulsion explosive in which a pre-­emulsion is formed from a fuel phase and a first part of an oxidizer phase, an oxidizing composition is prepared between a second part of the oxidizer phase and a void containing or void generating material for the explosive whereafter the pre-emulsion and the mixture are emulsified to form the final emulsion.
Patent ES-159763-A1 (ES)
Title: PERFECCIONAMIENTOS EN LOS APARATOS DE PROYECCIoN CINEMATOGRáFICA DE DESARROLLO CONTiNUO DE LA PELiCULA
Filed: 1942-12-22
Abstract: Perfeccionamientos en los aparatos de proyección cinematográfica de desarrollo contínuo de la película caracterizados porque comprenden una o varias lentes de entrada o de campo del sistema dispuestas detras del pasillo de desarrollo de la película.
Patent ES-177624-A1 (ES)
Title: Un cerrojo de seguridad u otro mecanismo analogo de cerrajeria
Filed: 1947-04-17
Abstract: Cerrojo u otro mecanismo de cerrajería que tiene trinquetes que cooperan con el cañón giratorio de guía de la llave para ponerse en encaje con uno de los bordes de la hendidura de paso de la misma y oponerse así a la rotación de dicho cañón mientras la hendidura no está exactamente llena delante de cada trinquete por una parte entera de la llave pudiendo dicho cerrojo o análogo presentar además las otras características que se exponen a continuación por separado o en combinación: a) El cañón es relativamente grueso y tiene muescas en las cuales penetran las puntas de los trinquetes. b) El cerrojo tiene una única lámina que asegura el bloqueo del pestillo en su sitio. c) El pestillo se acciona directamente desde el interior después de desaparecer la laminilla por medio de un botón de levantamiento de la misma.
Patent ES-177688-A1 (ES)
Title: Mejoras en o relativas a la fabricacion de terminaciones para cables de energia eléctrica
IPC: H02G15/06
Filed: 1947-04-21
Abstract: Mejoras en la fabricación de terminaciones para cables de energía eléctrica que tienen el extremo del cable colocado dentro de un tubo aislante en la que dicho tubo está unido sólidamente a un aislador de porcelana exterior.
Patent ES-188247-A1 (ES)
Title: Unas mejoras en las prensas para cortar tipos de filetaje de imprenta
Filed: 1949-05-17
Abstract: Unas mejoras en las prensas para cortar tipos de filetaje de imprenta caracterizadas por el hecho de que prescindiendo de los detalles constructivos de la prensa la cuchilla de cortar unida rígidamente al macho prensor presente su filo en forma de arco cóncavo; y sea solidaria con el punzón de la prensa y quede constantemente guiada por un soporte o plato elásticamente unido con el punzón que presenta un tope o platina que además de servir de apoyo y guía lateral para la cuchilla su testa o extremo inferior sirva para apoyarse sobre el fleje y evitar que se deforme o abarquille mientras actua la cuchilla.